Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

NYSE:BALY - New York Stock Exchange, Inc. - US05875B3042 - Common Stock - Currency: USD

12.5  0 (0%)

Fundamental Rating

2

Taking everything into account, BALY scores 2 out of 10 in our fundamental rating. BALY was compared to 136 industry peers in the Hotels, Restaurants & Leisure industry. BALY has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BALY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BALY has reported negative net income.
In the past year BALY had a positive cash flow from operations.
In the past 5 years BALY always reported negative net income.
Each year in the past 5 years BALY had a positive operating cash flow.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

BALY has a Return On Assets of -9.69%. This is amonst the worse of the industry: BALY underperforms 81.62% of its industry peers.
BALY has a worse Return On Equity (-1837.27%) than 67.65% of its industry peers.
Industry RankSector Rank
ROA -9.69%
ROE -1837.27%
ROIC N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

BALY's Gross Margin of 54.17% is fine compared to the rest of the industry. BALY outperforms 67.65% of its industry peers.
BALY's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BALY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

BALY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BALY has been increased compared to 1 year ago.
Compared to 5 years ago, BALY has more shares outstanding
BALY has a worse debt/assets ratio than last year.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.16, we must say that BALY is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BALY (0.16) is worse than 82.35% of its industry peers.
A Debt/Equity ratio of 106.77 is on the high side and indicates that BALY has dependencies on debt financing.
BALY's Debt to Equity ratio of 106.77 is on the low side compared to the rest of the industry. BALY is outperformed by 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 106.77
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACCN/A
WACC8.4%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.66 indicates that BALY may have some problems paying its short term obligations.
With a Current ratio value of 0.66, BALY is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
BALY has a Quick Ratio of 0.66. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.63, BALY is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.63
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BALY have decreased strongly by -56.97% in the last year.
The Revenue has been growing slightly by 0.06% in the past year.
BALY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.16% yearly.
EPS 1Y (TTM)-56.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.14%
Revenue 1Y (TTM)0.06%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-5.12%

3.2 Future

The Earnings Per Share is expected to grow by 23.45% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.69% on average over the next years.
EPS Next Y84.67%
EPS Next 2Y35.59%
EPS Next 3Y23.45%
EPS Next 5YN/A
Revenue Next Year3.23%
Revenue Next 2Y4.64%
Revenue Next 3Y0.69%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BALY indicates a somewhat cheap valuation: BALY is cheaper than 61.03% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.15
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

BALY's earnings are expected to grow with 23.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.59%
EPS Next 3Y23.45%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BALY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BALLY'S CORP

NYSE:BALY (5/1/2025, 8:46:37 PM)

12.5

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners2.67%
Inst Owner Change-0.07%
Ins Owners15.22%
Ins Owner Change-7.71%
Market Cap609.25M
Analysts50
Price Target17.03 (36.24%)
Short Float %0.21%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1476.46%
Min EPS beat(2)-2765.33%
Max EPS beat(2)-187.58%
EPS beat(4)1
Avg EPS beat(4)-801.9%
Min EPS beat(4)-2765.33%
Max EPS beat(4)15.03%
EPS beat(8)1
Avg EPS beat(8)-763.39%
EPS beat(12)3
Avg EPS beat(12)-710.71%
EPS beat(16)3
Avg EPS beat(16)-570.12%
Revenue beat(2)0
Avg Revenue beat(2)-4.62%
Min Revenue beat(2)-5.87%
Max Revenue beat(2)-3.37%
Revenue beat(4)0
Avg Revenue beat(4)-4.3%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-3.26%
Revenue beat(8)0
Avg Revenue beat(8)-3.44%
Revenue beat(12)0
Avg Revenue beat(12)-3.9%
Revenue beat(16)2
Avg Revenue beat(16)-2.82%
PT rev (1m)-3.03%
PT rev (3m)-3.03%
EPS NQ rev (1m)2.75%
EPS NQ rev (3m)41.55%
EPS NY rev (1m)20.84%
EPS NY rev (3m)19.91%
Revenue NQ rev (1m)-1.26%
Revenue NQ rev (3m)-0.51%
Revenue NY rev (1m)3.85%
Revenue NY rev (3m)3.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF 5.34
P/B 19.72
P/tB N/A
EV/EBITDA 10.15
EPS(TTM)-11.71
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)-2.75
FCFYN/A
OCF(TTM)2.34
OCFY18.71%
SpS50.28
BVpS0.63
TBVpS-63.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.69%
ROE -1837.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.17%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 106.77
Debt/FCF N/A
Debt/EBITDA 8.91
Cap/Depr 65.38%
Cap/Sales 10.13%
Interest Coverage N/A
Cash Conversion 30.79%
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.63
Altman-Z 0.16
F-Score4
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.14%
EPS Next Y84.67%
EPS Next 2Y35.59%
EPS Next 3Y23.45%
EPS Next 5YN/A
Revenue 1Y (TTM)0.06%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-5.12%
Revenue Next Year3.23%
Revenue Next 2Y4.64%
Revenue Next 3Y0.69%
Revenue Next 5YN/A
EBIT growth 1Y-108.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year386.98%
EBIT Next 3Y69.59%
EBIT Next 5YN/A
FCF growth 1Y57.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.03%
OCF growth 3Y11.25%
OCF growth 5Y3.91%